Cite

HARVARD Citation

    Di Raimondo, C. et al. (2022). Continuous low‐dose gemcitabine in primary cutaneous T cell lymphoma: A retrospective study. Dermatologic therapy. 35 (6), p. n/a. [Online]. 
  
Back to record